Luciferase Assay Kits Market Overview from 2024 to 2034

The luciferase assay market is poised to embark on an impressive growth trajectory, with a promising CAGR of 7.00%. Distinguished industry experts have forecasted that by the year 2034, the market is anticipated to soar to an astounding valuation of US$ 3,022.90 million, depicting a substantial upsurge from its present value of US$ 1,536.70 million

Attributes Details
Luciferase Assay Market Size, 2024 US$ 1,536.70 million
Market Size, 2034 US$ 3,022.90 million
Value CAGR (2024 to 2034) 7.00%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Luciferase Assay Market Dynamics

Drivers
  • The escalating need for drug discovery and development is anticipated to amplify the demand for luciferase assays in the coming years. By providing high sensitivity, compatibility, and a wide dynamic range, these assays emerge as invaluable in identifying potential drugs and optimizing their properties.
  • A sudden rise in genetic engineering and synthetic biology is expected to drive demand in the forecast period. Researchers can engineer luciferase enzymes with enhanced properties, such as improved brightness, stability, and substrate specificity.
Challenges
  • The lack of standardized protocols and quality control measures is expected to hinder luciferase assay demand in the future. Variability in assay conditions, reagents, and instrumentation may lead to inconsistencies in results, making it challenging to validate findings or replicate experiments
  • The surging adoption of alternative assay technologies and detection methods is expected to hamper market growth during the forecast period. These alternatives offer unique advantages and are much better suited for specific applications. Thus, consumers are using the alternatives which are best suited for their work.

Comparative View of Adjacent Markets

Apart from the luciferase assay market, an in-depth analysis has been done on two other related markets. The markets by name are the lateral flow assay market and the radioimmunoassay market

Increasing adoption of digital lateral flow assays is anticipated to amplify demand for lateral flow assays. On the other hand, advancements in medical technologies are anticipated to contribute to the growth of the radioimmunoassay market.

Luciferase Assay Market:

Attributes Luciferase Assay Market
Value-based CAGR (2024 to 2034) 7.00%
Market Trends Integration of automated platforms and software solutions for streamlined assay workflows
Growth Opportunities Growth potential in contract research organizations offering luciferase assay services for drug screening

Lateral Flow Assay Market:

Attributes Lateral Flow Assay Market
Value-based CAGR (2024 to 2034) 4.70%
Market Trends Growing demand for lateral flow tests for infectious diseases and pregnancy testing
Growth Opportunities Growth potential in personalized medicine with the development of targeted lateral flow assays

Radioimmunoassay Market:

Attributes Radioimmunoassay Market
Value-based CAGR (2024 to 2034) 3.8%
Market Trends Advancements in labeling techniques and detection systems for enhanced assay performance
Growth Opportunities Opportunities in developing radioimmunoassay kits for niche applications requiring radioactive detection
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

The Luciferase Assays Segment is dominating the Market by Product Type

Attributes Details
Product Type Luciferase Assays
Market share in 2024 35.00%

Luciferase assays are gaining popularity among researchers due to their compatibility with a wide range of products such as reagents, kits, and instruments. Moreover, the upsurge in drug discovery and development has led to the increasing adoption of these assays in recent years.

Furthermore, the increasing availability of advanced technologies, such as high-throughput screening systems and automated instrumentation, has made it easier to perform these assays on a large scale.

The Protein-protein Interaction Segment is dominating the Market by Application

Attributes Details
Application Protein-protein Interaction
Market Share in 2024 27.60%

Rising need for understanding complex cellular processes and developing effective drugs to treat specific diseases has led researchers to use protein-protein interactions as a common method. Increasing focus on personalized medicine is driving the growth of the protein-protein interaction segment.

Personalized medicine involves developing drugs tailored to the genetic makeup of individual patients. To do this, researchers need to study the interactions between specific proteins involved in disease pathways.

Country-wise Insights

Countries CAGR from 2024 to 2034
United States 3.20%
China 6.00%
Germany 2.50%
India 7.60%
Australia 5.30%

Government Funding and Evolving Test Techniques Fuel the Market in the United States

The CAGR of the market in the United States during the forecast period is anticipated to be 3.20%. The United States dominates the market in North America due to strong government financing for research into innovative test methodologies. Although demand for luciferase assays in this country has remained robust, operations targeting the market have recently shifted.

China’s Luciferase Market Thrives with an Increasing Need for Drug Discoveries

The market is expected to register a CAGR of 6.00% in China through 2034. The government plays a major role in the growth of the luciferase assay market in China by providing funding and facilities for drug discoveries and development.

China has greater development potential in this industry. Many firms are focusing their resources on economically growing regions, especially in the Asia Pacific, to explore product potential that is expected to increase luciferase assay sales.

Laboratories in Germany Embrace Luciferase Assays for Advanced Detection

The market is expected to progress at a CAGR of 2.50% in Germany throughout the forecast period. The need for advanced technology is anticipated to drive the luciferase assay market in Germany.

By providing high sensitivity, low background, and real-time detection capabilities, these assays are gaining more market potential than traditional methods in the country. Moreover, the high usage of luciferase assays in laboratories across Germany, especially for pharmaceutical purposes, has been observed in recent years.

Australia’s Assay Market Surges with Research and Development Demand

The market is expected to progress at a CAGR of 5.30% in Australia throughout the forecast period. Escalating demand for biotechnology and life science research is driving up the demand for the luciferase assay market in the region. Moreover, the expanding pharmaceutical industry is anticipated to gain a major market share in Australia in the coming years.

India’s Luciferase Market Thrives with Personalized Medicine

The market is expected to progress at a CAGR of 7.60% in India. Advancements in technology have led to the development of new and improved luciferase assay kits, making them more accessible and affordable to researchers and scientists in India.

Moreover, the luciferase assay market in India is expected to grow due to the increasing demand for personalized medicine in the region. As personalized medicine becomes more prevalent, there will be a need for more precise and efficient tools to diagnose and treat diseases.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The luciferase assay market is highly competitive, with numerous players involved in the development and production of assay kits and reagents. Companies are constantly innovating and launching new products to stay ahead of the competition.

Additionally, partnerships, collaborations, and mergers and acquisitions are common strategies these players adopt to expand their market presence and enhance their product portfolio.

Company Portfolio

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a leading biotechnology company that offers a wide range of products and services to the life science, healthcare, and industrial markets. The company has a global presence and operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

One of the key products offered by Thermo Fisher Scientific Inc. is its range of Luciferase Assays. These assays are designed to measure the activity of luciferase enzymes, which are commonly used as reporter genes in molecular biology research.

The assay kits offered by Thermo Fisher Scientific Inc. are used to measure the expression of genes, monitor protein-protein interactions, and detect changes in cellular signaling pathways.

PerkinElmer Inc.

PerkinElmer Inc. is a global leader in providing innovative products, services, and solutions to the life sciences, diagnostics, and applied markets. The company's diverse portfolio includes a wide range of products, including analytical instruments, reagents, software, and consumables.

PerkinElmer's luciferase assays are among its most popular products, offering researchers a range of options for measuring gene expression and monitoring cellular signaling pathways.

PerkinElmer's assays are designed to be highly sensitive, reliable, and easy to use. The company offers a range of assay formats, including reporter gene assays, dual-luciferase reporter assays, and firefly assay kits.

Acquisition, Mergers, and Recent Development

  • In 2018, Thermo Fisher Scientific, a leading manufacturer of scientific research products and services, announced its acquisition of the Advanced Bioprocessing business from BD. With this acquisition, Thermo Fisher Scientific aims to expand its product portfolio of cell-culture media and strengthen its technical services program. The move reflects Thermo Fisher's commitment to providing innovative solutions for the life sciences industry and its ongoing efforts to enhance the quality and efficiency of bioprocessing.
  • In 2018, Merck, a leading science and technology company, inaugurated a state-of-the-art laboratory in Singapore. The 3,800-square-meter laboratory is equipped with cutting-edge technologies and is designed to support Merck's research and development efforts in the Asia-Pacific region. The laboratory will focus on developing new products and solutions in the areas of life sciences, pharmaceuticals, and performance materials. The facility will also serve as a regional hub for Merck's collaborations with academic and industry partners in the region. With the new laboratory, Merck aims to strengthen its presence in the Asia Pacific market and accelerate its innovation efforts in the region.

Global Luciferase Assay Market Report Scope

Attribute Details
Estimated Market Size (2024) US$ 1,536.70 million
Projected Market Size (2034) US$ 3,022.90 million
Anticipated Growth Rate (2024 to 2034) 7.00%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis US$ million or billion for Value and Units for Volume
Key Regions Covered North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa
Key Segments Covered Product Type and Application
Key Companies Profiled
  • Promega Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Abcam plc
  • Geno Technology Inc.
  • BioTek Instruments, Inc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Cell Signaling Technology, Inc.
  • Danaher Corporation.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Segments

By Product Type:

  • Beta-galactosidase assays
  • Luciferase assays
  • Fluorescent protein-related assays
  • Chloramphenicol acetyltransferase assays

By Application:

  • Gene expression
  • Post-translational modification
  • Protein-protein interaction
  • Metabolic activity
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

How will the Luciferase Assay Industry Progress in the United States?

The CAGR of the market in the United States from 2024 to 2034 is estimated to be 3.20%.

What is the Scope of the Luciferase Assay Market?

The market is expected to grow at a CAGR of 7.00%.

How Big is the Luciferase Assay Market?

The market size is expected to be worth US$ 1,536.70 million in 2024.

How will the Luciferase Assay Industry Progress in China?

The CAGR of the market in China from 2024 to 2034 is estimated to be 6.00%.

How Big will the Luciferase Assay Market be by 2034?

The market is estimated to get as big as US$ 3,022.90 million by 2034.

What are the Key Market Segments of Luciferase Assay?

The market can be divided into the following segments: product type, application, and region.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Assay Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Assay Type, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Assay Type, 2024 to 2034

        5.3.1. Beta-Galactosidase Assays

        5.3.2. Fluorescent Protein Related Assays

        5.3.3. Chloramphenicol Acetyltransferase Assays

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Assay Type, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Assay Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        6.3.1. Gene Expression

        6.3.2. Post-Translational Modification

        6.3.3. Protein-Protein Interaction

        6.3.4. Metabolic Activity

        6.3.5. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Assay Type

        8.2.3. By Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Assay Type

        8.3.3. By Application

    8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Assay Type

        9.2.3. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Assay Type

        9.3.3. By Application

    9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Assay Type

        10.2.3. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Assay Type

        10.3.3. By Application

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Assay Type

        11.2.3. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Assay Type

        11.3.3. By Application

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Assay Type

        12.2.3. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Assay Type

        12.3.3. By Application

    12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Assay Type

        13.2.3. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Assay Type

        13.3.3. By Application

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Assay Type

        14.2.3. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Assay Type

        14.3.3. By Application

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2023

            15.1.2.1. By Assay Type

            15.1.2.2. By Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2023

            15.2.2.1. By Assay Type

            15.2.2.2. By Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2023

            15.3.2.1. By Assay Type

            15.3.2.2. By Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2023

            15.4.2.1. By Assay Type

            15.4.2.2. By Application

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2023

            15.5.2.1. By Assay Type

            15.5.2.2. By Application

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2023

            15.6.2.1. By Assay Type

            15.6.2.2. By Application

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2023

            15.7.2.1. By Assay Type

            15.7.2.2. By Application

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2023

            15.8.2.1. By Assay Type

            15.8.2.2. By Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2023

            15.9.2.1. By Assay Type

            15.9.2.2. By Application

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2023

            15.10.2.1. By Assay Type

            15.10.2.2. By Application

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2023

            15.11.2.1. By Assay Type

            15.11.2.2. By Application

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2023

            15.12.2.1. By Assay Type

            15.12.2.2. By Application

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2023

            15.13.2.1. By Assay Type

            15.13.2.2. By Application

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2023

            15.14.2.1. By Assay Type

            15.14.2.2. By Application

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2023

            15.15.2.1. By Assay Type

            15.15.2.2. By Application

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2023

            15.16.2.1. By Assay Type

            15.16.2.2. By Application

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2023

            15.17.2.1. By Assay Type

            15.17.2.2. By Application

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2023

            15.18.2.1. By Assay Type

            15.18.2.2. By Application

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2023

            15.19.2.1. By Assay Type

            15.19.2.2. By Application

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2023

            15.20.2.1. By Assay Type

            15.20.2.2. By Application

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2023

            15.21.2.1. By Assay Type

            15.21.2.2. By Application

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2023

            15.22.2.1. By Assay Type

            15.22.2.2. By Application

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2023

            15.23.2.1. By Assay Type

            15.23.2.2. By Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Assay Type

        16.3.3. By Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Life Technologies

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Sigma Aldrich

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Thermo Fisher

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Promega

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Roche Applied Sciences

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Switchgear Genomics

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. OriGene

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. EMD Millipore

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Clontech

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Gold Biotechnology

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

        17.1.11. Lonza

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

        17.1.12. GE Healthcare Life Sciences.

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodolog

Recommendations

Healthcare

Lateral Flow Assays Market

February 2022

REP-GB-14271

August 2023

325 pages

Healthcare

Radioimmunoassay Market

January 2016

REP-GB-1196

June 2023

221 pages

Healthcare

Transport Protein Assays Kits Market

September 2024

REP-GB-10989

Upcoming

Healthcare

Cytotoxicity Assays Market

September 2024

REP-GB-10024

Upcoming

Explore Healthcare Insights

View Reports